Annual ROA
-37.24%
+4.20%+10.14%
31 December 2023
Summary:
Adaptimmune Therapeutics annual return on assets is currently -37.24%, with the most recent change of +4.20% (+10.14%) on 31 December 2023. During the last 3 years, it has risen by +3.88% (+9.44%). ADAP annual ROA is now -375.00% below its all-time high of -7.84%, reached on 01 December 2015.ADAP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-15.08%
+9.06%+37.53%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly return on assets is currently -15.08%, with the most recent change of +9.06% (+37.53%) on 30 September 2024. Over the past year, it has increased by +14.88% (+49.67%). ADAP quarterly ROA is now -1008.82% below its all-time high of -1.36%, reached on 30 September 2015.ADAP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | +49.7% |
| 3 y3 years | +9.4% | +59.6% |
| 5 y5 years | -8.8% | +72.7% |
ADAP ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.4% | +10.1% | at high | +72.9% |
| 5 y | 5 years | -8.8% | +37.8% | at high | +74.1% |
| alltime | all time | -375.0% | +92.0% | -1008.8% | +74.1% |
Adaptimmune Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -15.08%(-37.5%) |
| June 2024 | - | -24.14%(-56.6%) |
| Mar 2024 | - | -55.64%(+50.4%) |
| Dec 2023 | -37.24%(-10.1%) | -36.99%(+23.5%) |
| Sept 2023 | - | -29.96%(+10.6%) |
| June 2023 | - | -27.08%(-16.6%) |
| Mar 2023 | - | -32.48%(-23.9%) |
| Dec 2022 | -41.44%(+20.7%) | -42.67%(-4.3%) |
| Sept 2022 | - | -44.58%(+2.3%) |
| June 2022 | - | -43.56%(+4.4%) |
| Mar 2022 | - | -41.72%(+9.6%) |
| Dec 2021 | -34.34%(-16.5%) | -38.08%(+1.9%) |
| Sept 2021 | - | -37.37%(+12.6%) |
| June 2021 | - | -33.18%(+1.6%) |
| Mar 2021 | - | -32.65%(-4.2%) |
| Dec 2020 | -41.12%(-31.3%) | -34.07%(-7.6%) |
| Sept 2020 | - | -36.86%(-17.0%) |
| June 2020 | - | -44.41%(-23.7%) |
| Mar 2020 | - | -58.19%(-0.2%) |
| Dec 2019 | -59.86% | -58.29%(+5.6%) |
| Sept 2019 | - | -55.18%(+45.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -38.02%(-2.1%) |
| Mar 2019 | - | -38.85%(+7.5%) |
| Dec 2018 | -34.24%(+25.9%) | -36.15%(+12.3%) |
| Sept 2018 | - | -32.19%(-8.3%) |
| June 2018 | - | -35.11%(+39.5%) |
| Mar 2018 | - | -25.16%(-1.9%) |
| Dec 2017 | -27.20%(-1.1%) | -25.65%(+15.2%) |
| Sept 2017 | - | -22.27%(-26.8%) |
| June 2017 | - | -30.44%(-4.2%) |
| Mar 2017 | - | -31.77%(+11.5%) |
| Dec 2016 | -27.51%(+250.9%) | -28.50%(+14.8%) |
| Sept 2016 | - | -24.82%(+43.0%) |
| June 2016 | - | -17.36%(+84.9%) |
| Mar 2016 | - | -9.39%(+590.4%) |
| Dec 2015 | -7.84%(-36.7%) | - |
| Sept 2015 | - | -1.36%(-73.0%) |
| June 2015 | -12.39%(-40.7%) | - |
| Dec 2014 | - | -5.03%(-14.5%) |
| Sept 2014 | - | -5.88% |
| June 2014 | -20.90%(-95.5%) | - |
| June 2013 | -467.49% | - |
FAQ
- What is Adaptimmune Therapeutics annual return on assets?
- What is the all time high annual ROA for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual ROA year-on-year change?
- What is Adaptimmune Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly ROA year-on-year change?
What is Adaptimmune Therapeutics annual return on assets?
The current annual ROA of ADAP is -37.24%
What is the all time high annual ROA for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual return on assets is -7.84%
What is Adaptimmune Therapeutics annual ROA year-on-year change?
Over the past year, ADAP annual return on assets has changed by +4.20% (+10.14%)
What is Adaptimmune Therapeutics quarterly return on assets?
The current quarterly ROA of ADAP is -15.08%
What is the all time high quarterly ROA for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly return on assets is -1.36%
What is Adaptimmune Therapeutics quarterly ROA year-on-year change?
Over the past year, ADAP quarterly return on assets has changed by +14.88% (+49.67%)